Related Experiment Video

Updated: Jun 20, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Lessons in signaling and tumorigenesis from polyomavirus middle T antigen

Michele M Fluck1, Brian S Schaffhausen

  • 1Department of Microbiology and Molecular Genetics, Interdepartmental Program in Cell and Molecular Biology, Michigan State University, East Lansing, MI 48824, USA. fluck@msu.edu

Microbiology and Molecular Biology Reviews : MMBR
|September 2, 2009
PubMed

Insights

Murine polyomavirus middle T antigen drives cancer signaling in eukaryotic cells. The MMTV-PyMT mouse model reveals tumor progression from hyperplasia to metastasis, offering insights into breast cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • Small DNA tumor viruses are crucial tools for understanding eukaryotic cell biology.
  • Recent research focuses on viral mechanisms in cancer-related signaling pathways.

Purpose of the Study:

  • To review the mechanisms and downstream pathways of murine polyomavirus middle T antigen-induced transformation.
  • To highlight the MMTV-PyMT transgenic mouse as a model for studying breast cancer progression in situ.

Main Methods:

  • Review of existing literature on polyomavirus middle T antigen.
  • Focus on the MMTV-PyMT transgenic mouse model for in situ tumor progression studies.

Main Results:

  • Murine polyomavirus middle T antigen activates critical cancer-related signaling pathways.
  • The MMTV-PyMT model allows observation of tumor development from hyperplasia to metastasis.

Conclusions:

  • Murine polyomavirus middle T antigen is a significant factor in cellular transformation and cancer development.
  • The MMTV-PyMT mouse model is invaluable for dissecting the stages of breast cancer progression.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety14:03

Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety

Published on: July 24, 2011

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...